BB Pureos Bioventures

Investor type

CVC

Founded

2017

AUM

$205 M

Location

Freienbach, Schwyz, Switzerland

$0-1 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Profile

Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and
neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.

Industry

Healthcare Services HealthTech Biotechnology Pharmaceuticals Medical Devices Life Sciences

Region of investment

North America Europe

BB Pureos Bioventures Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
BB Pureos Bioventures LP
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
Life Sciences
Pre-seed
Seed
North America
Europe
Asia
$5-10 m
$205 M
April 2021

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
wuZLir0d1eKDpAxH wuZLir0d1eKDpAxH
wuZLir0d1eKDpAxH
avatar
wuZLir0d1eKDpAxH wuZLir0d1eKDpAxH
wuZLir0d1eKDpAxH
avatar
wuZLir0d1eKDpAxH wuZLir0d1eKDpAxH
wuZLir0d1eKDpAxH
avatar
wuZLir0d1eKDpAxH wuZLir0d1eKDpAxH
wuZLir0d1eKDpAxH
avatar
wuZLir0d1eKDpAxH wuZLir0d1eKDpAxH
wuZLir0d1eKDpAxH
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!